Ann Arbor staging system (historical)

Changed by Hamish Smith, 19 Oct 2018

Updates to Article Attributes

Body was changed:

The Ann Arbor staging system is the landmark lymphoma staging classification system for both Hodgkin lymphoma and non-Hodgkin lymphoma

It is named after Ann Arbor, Michigan where the Committee on Hodgkin's Disease Staging Classification met in 1971 to agree on it. It has since been updated and modified a number of times, notably as the Cotswolds-modified Ann Arbor classification, the Lugano classification and the most current LYRIC classification.

Staging system

  • stage I: involvement of a single lymph node region or of a single extralymphatic organ or site
  • stage II: involvement of two or more lymph node regions on the same side of the diaphragm or localizedlocalised involvement of an extralymphatic organ/site or site 
  • stage III: involvement of lymph node regions or structures on both sides of the diaphragm
  • stage IV: diffuse or disseminated involvement of one or more extralymphatic organs, or either: 
    • isolated extralymphatic organ involvement without adjacent regional lymph node involvement, but with disease in distant site(s)sites
    • involvement of the liver, bone marrow, pleura or CSF

Additional stagingsub-staging variables include:

  • A: asymptomatic
  • B: presence of B symptoms (fever(including fever, night sweats and weight loss of over 10% of body weight over 6 months)
  • E: Involvement of a single, extranodal site contiguous or proximal to a known nodal site (stages I to III only; additional extranodal involvement is stage IV)
  • S: splenic involvement
  • X: bulky nodal disease: nodal mass >1/3 of intrathoracic diameter or 10 cm in dimension
  • -<strong>stage II:</strong> involvement of two or more lymph node regions on the same side of the diaphragm or localized involvement of an extralymphatic organ/site </li>
  • +<strong>stage II:</strong> involvement of two or more lymph node regions on the same side of the diaphragm or localised involvement of an extralymphatic organ or site </li>
  • -<li>isolated extralymphatic organ involvement without adjacent regional lymph node involvement, but with disease in distant site(s)</li>
  • +<li>isolated extralymphatic organ involvement without adjacent regional lymph node involvement, but with disease in distant sites</li>
  • -</ul><p>Additional staging variables:</p><ul>
  • +</ul><p>Additional sub-staging variables include:</p><ul>
  • -<strong>B:</strong> presence of B symptoms (fever, night sweats and weight loss)</li>
  • +<strong>B:</strong> presence of B symptoms (including fever, night sweats and weight loss of over 10% of body weight over 6 months)</li>
  • -<strong>E</strong>: Involvement of a single, extranodal site contiguous or proximal to a known nodal site (stages I to III only; additional extranodal involvement is stage IV</li>
  • +<strong>E</strong>: Involvement of a single, extranodal site contiguous or proximal to a known nodal site (stages I to III only; additional extranodal involvement is stage IV)</li>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.